• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从芋螺毒素到竞争性 MC4R 拮抗剂。

From a Cone Snail Toxin to a Competitive MC4R Antagonist.

机构信息

Health and Life Sciences Department, Université Paris Saclay, French Alternative Energies and Atomic Energy Commission (CEA), CEA Saclay, Bat 152, 91191 Gif sur Yvette, France.

Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

出版信息

J Med Chem. 2022 Sep 22;65(18):12084-12094. doi: 10.1021/acs.jmedchem.2c00786. Epub 2022 Sep 5.

DOI:10.1021/acs.jmedchem.2c00786
PMID:36063022
Abstract

The melanocortin 4 receptor (MC4R) plays a role in energy homeostasis and represents a target for treating energy balance disorders. For decades, synthetic ligands have been derived from MC4R endogenous agonists and antagonists, such as setmelanotide used to treat rare forms of genetic obesity. Recently, animal venoms have demonstrated their capacity to provide melanocortin ligands with toxins from a scorpion and a spider. Here, we described a cone snail toxin, N-CTX-Ltg1a, with a nanomolar affinity for hMC4R but unrelated to any known toxins or melanocortin ligands. We then derived from the conotoxin the linear peptide HT1-0, a competitive antagonist of , , and β-arrestin2 pathways with a low nanomolar affinity for hMC4R. Similar to endogenous ligands, HT1-0 needs hydrophobic and basic residues to bind hMC4R. Altogether, it represents the first venom-derived peptide of high affinity on MC4R and paves the way for the development of new MC4R antagonists.

摘要

黑皮质素 4 受体 (MC4R) 在能量平衡中发挥作用,是治疗能量平衡紊乱的靶点。几十年来,合成配体一直是从 MC4R 内源性激动剂和拮抗剂衍生而来的,例如用于治疗罕见遗传性肥胖症的 setmelanotide。最近,动物毒液已证明其具有提供黑皮质素配体的能力,这些配体来自蝎子和蜘蛛的毒素。在这里,我们描述了一种芋螺毒素,N-CTX-Ltg1a,对 hMC4R 的亲和力为纳摩尔级,但与任何已知的毒素或黑皮质素配体无关。然后,我们从该芋螺毒素衍生出线性肽 HT1-0,它是一种竞争性拮抗剂,对 , 和β-arrestin2 途径具有低纳摩尔级亲和力,对 hMC4R 的亲和力为纳摩尔级。与内源性配体类似,HT1-0 需要疏水性和碱性残基来结合 hMC4R。总的来说,它代表了第一个对 MC4R 具有高亲和力的毒液衍生肽,为开发新的 MC4R 拮抗剂铺平了道路。

相似文献

1
From a Cone Snail Toxin to a Competitive MC4R Antagonist.从芋螺毒素到竞争性 MC4R 拮抗剂。
J Med Chem. 2022 Sep 22;65(18):12084-12094. doi: 10.1021/acs.jmedchem.2c00786. Epub 2022 Sep 5.
2
Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.内源性促阿黑皮素原衍生激动剂、合成激动剂和内源性肥胖相关蛋白拮抗剂对 30 个人黑色素皮质素 4 受体多态性的药理学特征分析。
Biochemistry. 2010 Jun 8;49(22):4583-600. doi: 10.1021/bi100068u.
3
Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.新型药理学 MC4R 激动剂可有效激活肥胖患者中内源性激动剂反应受损的突变型 MC4R。
J Endocrinol. 2010 Nov;207(2):177-83. doi: 10.1677/JOE-09-0336. Epub 2010 Aug 9.
4
Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.通过计算模拟方法深入了解作为一种强效的、首创的黑皮质素-4 受体(MC4R)激动剂的赛美曲肽(RM-493)的别构机制,以治疗罕见的肥胖遗传疾病。
ACS Chem Neurosci. 2019 Mar 20;10(3):1055-1065. doi: 10.1021/acschemneuro.8b00346. Epub 2018 Aug 13.
5
Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.三种不同配体下 MC4R 突变的差异信号特征。
Int J Mol Sci. 2020 Feb 12;21(4):1224. doi: 10.3390/ijms21041224.
6
Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.通过同源分子建模和使用嵌合肽配体进行验证来鉴定假定的刺鼠相关蛋白(87-132)-促黑素皮质素4受体相互作用。
J Med Chem. 2004 Apr 22;47(9):2194-207. doi: 10.1021/jm0303608.
7
Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity.负责拮抗剂SHU9119选择性活性的人促黑素皮质激素4受体的分子决定因素。
J Biol Chem. 2002 Jun 7;277(23):20328-35. doi: 10.1074/jbc.M201343200. Epub 2002 Mar 23.
8
Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R.发现人类黑色素皮质素-4 受体 (hMC4R) 天冬氨酸 189 (D189) 氨基酸与内源性 G 蛋白偶联受体 (GPCR) 拮抗剂 Agouti 相关蛋白 (AGRP) 的分子相互作用,为 AGRP 在 hMC4R 上的反向激动剂药理学提供了深入了解。
ACS Chem Neurosci. 2021 Feb 3;12(3):542-556. doi: 10.1021/acschemneuro.0c00755. Epub 2021 Jan 20.
9
Novel binding motif of ACTH analogues at the melanocortin receptors.促肾上腺皮质激素类似物在黑皮质素受体上的新型结合基序。
Biochemistry. 2009 Oct 20;48(41):9775-84. doi: 10.1021/bi900634e.
10
Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.肽和小分子可挽救功能失调的人类黑皮质素-4受体多态性的功能活性和激动剂效力。
Biochemistry. 2007 Jul 17;46(28):8273-87. doi: 10.1021/bi7007382. Epub 2007 Jun 23.

引用本文的文献

1
Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases.天然肽毒素作为重新治疗2型血管加压素受体相关疾病的一种选择。
Biology (Basel). 2023 Apr 3;12(4):544. doi: 10.3390/biology12040544.